Lucy Hemsley-Faulconbridge

faculty photo
Clinical Assistant Professor of Psychology in Psychiatry
Director of Research, Center for Weight and Eating Disorders, University of Pennsylvania Perelman School of Medicine
Department: Psychiatry

Contact information
Center for Weight and Eating Disorders, University of Pennsylvania School of Medicine, 3535 Market Street,
Philadelphia, PA 19104-4283
Office: 215-746-7191
Fax: 215-898-2878
BA (Experimental Psychology)
University of St Andrews, Fife, Scotland, 2000.
MA (Psychology)
University of Pennsylvania, 2002.
PhD (Psychology)
University of Pennsylvania, 2007.
Permanent link

Description of Research Expertise

Dr. Faulconbridge’s research interests currently focus on the co-morbidity of obesity with mental health problems, particularly major depressive disorder. She is interested in changes in mood following weight reduction, as well as the relationship between weight change and risk factors for cardiovascular disease. Dr. Faulconbridge is the recipient of a Mentored Patient Oriented Research Award (K23), funded by the National Heart Lung and Blood Institute, and is currently conducting a randomized controlled trial to evaluate three treatments for obese individuals with comorbid major depressive disorder who are at high risk for cardiovascular disease. Dr. Faulconbridge also has expertise in the neural, endocrine, and psychological outcomes following bariatric surgery and non-surgical weight loss.

Description of Itmat Expertise

Dr. Faulconbridge’s research interests focus on the co-morbidity of obesity with mental illness, particularly depression. She is interested in the triangular relationship between depression, obesity and cardiovascular disease, both from an etiological and a treatment perspective. Her research is currently funded by a K23 award from the National Heart, Lung and Blood Institute to examine a novel treatment for obese, depressed individuals at risk for cardiovascular disease. In addition, Dr. Faulconbridge is interested in translational research addressing the amelioration of type 2 diabetes and weight loss following bariatric surgery.

Selected Publications

Alamuddin, N., Vetter, ML., Ahima, RS, Hesson, L, Minnick, A., Faulconbridge, LF., Allison, KC., Sarwer, DB, Chittams, J, Williams, NN., Hayes, MR., Loughead, JW., Gur, R, Wadden, TA: Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: An 18-month controlled study. Obesity Surgery 2016.

Faulconbridge, L.F., Ruparel, K., Loughead, J.W., Allison, K.C., Hesson, L.A., Fabricatore, A. Baxley, A. Ritter, S., Hopson, R.D., Sarwer, D., Williams, N., Geliebter, A., Gur, R.C. Wadden, T.A. : Changes in neural responsivity to highly-palatable foods following Roux-en-Y gastric bypass, sleeve gastrectomy, or weight stability: an fMRI study. Obesity 24(5): 1054-60, 2016.

Bechtel, C., Hopkins, CM., Bailer, B., Bishop-Gilyard, CT., Carvajal, R., Wadden, TA., Faulconbridge, LF: Changes in Health-related Quality of Life in Obese Individuals with Depression at risk for CVD: Results from a Randomized Controlled Trial. Presented at the Association for Cognitive and Behavioral Therapies Annual Meeting in Chicago, IL November 2015.

Faulconbridge, L.F., Bechtel, C. Hopkins, CM., Bailer-Benforardo, B., Bishop-Gilyard, C., Carvajal, R., Berkowitz, RI., DeRubeis R., Wadden, TA: Treatment for depression does not augment behavioral weight control in obese, depressed individuals: a randomized controlled trial. Presented at the The Obesity Society Annual Meeting in Los Angeles, CA. November 2015.

Faulconbridge, L.F.: Interviewed for Brave Endurance Wellness Podcast with James Kelley, PhD, Wayne, PA October 16 2015.

Alison, K.C., Faulconbridge, L.F., Hesson, L., Ritter, S., Minnick, A., Ruparel, K., Sarwer, D.B., Geliebter, A., Gur, R., Wadden, T.A. : Changes over six months in food palatability and appetite in Roux-en-Y gastric bypass (RYGB), vertical sleeve gastrectomy (VSG), and control (C) participants. Presented at the International Conference on Eating Disorders, Boston, Massachusetts April 2015.

Faulconbridge, L.F.: Interview with Mitzi Purdue for Women’s Health Congress. Washington, DC Apriil 17 2015.

Faulconbridge, L.F., Hopkins, C.M: Behavior Modification for the Obese Person with Depression: Is It Enough? Behavior Modification: Programs, Techniques, and Effectiveness. NOVA Science Publishers, New York, 2015.

McCaffery, J.M., Papandonatos, G.D., Faulconbridge, L.F., Peter, I., Wagenknecht, L., Pajewski, N., Anderson, A., Wing, R.R., Wadden, T.A., the Look AHEAD Research Group: Genetic predictors of depressive symptoms in the Look AHEAD Trial. Psychosomatic Medicine 77(9): 982-92, 2015.

Faulconbridge, L.F., Ruparel, K., Allison, K.C., Hesson, L.A., Baxley, A., Ritter, S., Hopson, R.D., Williams, N., Gur, R.C., Wadden, T.A. : Changes in neural responsivity to highly-palatable foods following Roux-en-Y gastric bypass surgery, sleeve gastrectomy, or weight stability: an fMRI study. Presented at the Obesity Society Annual Meeting, Boston, Massachusetts November 2014.

back to top
Last updated: 02/17/2017
The Trustees of the University of Pennsylvania